Medical Improvisation Study

February 2, 2026 updated by: University of California, San Francisco

Enhancing Communication and Cognitive Resilience in Surgical Trainees Through Medical Improvisation

This study offers improvisation training for otolaryngology residents to see if there is any impact on connection, stress, and mood. A control group of otolaryngology residents continues their standard medical education with no improvisation.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94143
        • UCSF

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Otolaryngology Resident at UCSF

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Improvisation Group
Otolaryngology Residents taking Improvisation Training
3 Online Group Improvisation Training classes led by a professional is offered every other week for 1 hour to the experimental cohort.
Active Comparator: Control Group
This control group of OHNS residents continues their standard medical education.
OHNS residents continue the existing standard medical education.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Connection: Social Connectiveness Scale
Time Frame: 6 weeks
Team dynamics and interpersonal connectedness are assessed using the Social Connectedness Scale. This is a custom survey developed specifically for this study to measure participants' sense of belonging and connection within the residency program. The scale consists of 5 items rated on a 5-point Likert scale. Total scores range from 0 to 25, with higher scores indicating a greater sense of connectedness (better outcome).
6 weeks
Clinical Decision Making Accuracy and Response Time
Time Frame: 6 weeks
Clinical decision-making under pressure is assessed using the "Intraoperative Vignettes" assessment. This is a computer-based cognitive test comprising 20 Otolaryngology-Head and Neck Surgery (OHNS) case scenarios. Participants are presented with clinical scenarios and must select the correct management decision. The outcome is reported as a composite of accuracy (total number of correct responses) and response time (time taken to select an answer). Accuracy is scored from 0 to 20, with higher scores indicating better clinical decision-making.
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mood (PANAS)
Time Frame: 6 weeks

Mood is assessed using the Positive and Negative Affect Schedule (PANAS). This is a validated 20-item self-report questionnaire that measures two distinct dimensions of emotion: Positive Affect (10 items) and Negative Affect (10 items). Participants rate items on a 5-point scale ranging from 1 (Very slightly or not at all) to 5 (Extremely). Scores for each subscale range from 10 to 50.

  • Positive Affect: Higher scores represent higher levels of enthusiasm and energy (better outcome).
  • Negative Affect: Higher scores represent higher levels of subjective distress and unpleasurable engagement (worse outcome).
6 weeks
Anxiety and Depression (DASS-21)
Time Frame: 6 weeks

Psychological distress is measured using the Depression, Anxiety, and Stress Scale-21 (DASS-21). This is a validated 21-item self-report instrument containing three subscales: Depression, Anxiety, and Stress (7 items per subscale). Participants rate how much each statement applied to them over the past week on a 4-point scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much or most of the time). Subscale scores are calculated by summing the scores for the relevant items and multiplying by 2.

  • Range: Each subscale ranges from 0 to 42.
  • Interpretation: Higher scores indicate greater severity of symptoms (worse outcome).
6 weeks
Intervention Satisfaction Score (Intervention Arm Only)
Time Frame: 6 weeks
Participants in the intervention group complete an Intervention Satisfaction Survey to evaluate the curriculum and learner experience. This measure utilizes a Likert scale to assess participant feedback. Items are rated on a 5-point scale from 1 (Not true at all) to 5 (Completely true), with higher scores indicating higher satisfaction (better outcome).
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karen Barrett, PhD, University of California, San Francisco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2025

Primary Completion (Estimated)

February 1, 2026

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

January 2, 2026

First Submitted That Met QC Criteria

January 12, 2026

First Posted (Actual)

January 21, 2026

Study Record Updates

Last Update Posted (Actual)

February 5, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 25-44724

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychosocial Problem

Clinical Trials on Group Online Improvisation Training

Subscribe